Appendix 3X Initial Director’s Interest Notice + See chapter 19 for defined terms. 11/3/2002 Appendix 3X Page 1 Rule 3.19A.1 Appendix 3X Initial Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents...
Initial Director's Interest Notice
Filed with ASX ·
6ix hasn’t read this filing yet.
Percheron Therapeutics Limited on 6ix
Earlier from Percheron Therapeutics
- Dr Michael Baker Commences as CEO and MD
- Notice under S708A
- Application for quotation of securities - PER
- 2026 Notice of Annual General Meeting
- Percheron Therapeutics Limited Corporate Presentation
Later from Percheron Therapeutics
- Final Director's Interest Notice
- Proposed issue of securities - PER
- Annual General Meeting - Chair Address
- Annual General Meeting - Management Presentation
- Results of Annual General Meeting
